# Sanofi-Aventis Deutschland GmbH – FDA Inspection, Mar 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/sanofi-aventis-deutschland-gmbh/c34bec9c-4453-44d0-bcba-d9df811b7c10
Source feed: FDA_Inspections

> FDA inspection 1006001 of Sanofi-Aventis Deutschland GmbH, March 03, 2017. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006001
- Company Name: Sanofi-Aventis Deutschland GmbH
- Inspection Date: 2017-03-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1262770 - 2025-01-16](https://www.keypedia.com/records/fda_inspections/sanofi-aventis-deutschland-gmbh/348390ff-d4e4-4542-a78b-5ee0f5c4d748)
- FDA Inspection 1215824 - 2022-03-25
- [FDA Inspection 1094836 - 2019-05-14](https://www.keypedia.com/records/fda_inspections/sanofi-aventis-deutschland-gmbh/8ee42dad-b559-446f-9c69-d3ad6a8d8521)
- FDA Inspection 952968 - 2015-12-10
- FDA Inspection 933399 - 2015-06-26

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/junho-pak/4abe53fb-ad20-490d-9e71-6216a9f863f5)

Company: https://www.keypedia.com/companies/sanofi-aventis-deutschland-gmbh/07c96432-bb43-45e5-a80d-e4bca284dbab

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
